Sofwave for face and neck: Sofwave is particularly effective for post-weight loss facial skin tightening
doi: 10.1152/ajpendo.00057.2018
Data from the STEP clinical trials showed semaglutide 2.4 mg reduced CRP by 44% in STEP 1, 39% in STEP 2, and 48% in STEP 3 compared to placebo
A 2025 study comparing the GLP-1 pill with the GLP-1 injection found their effectiveness for lowering blood sugar and aiding weight loss in adults with type 2 diabetes were comparable
Calorie & TDEE Calculator Estimate resting energy needs and daily calorie range from age, sex, body size, and activity level
Press release: Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy in a pill ) at ObesityWeek 2025, including demonstrated reductions in cardiovascular risk factors.* Retrieved from Rosenstock, J., Hsia, S., Ruiz, L